Revolutionizing Anti-Allergy Medications: A Comprehensive Review of Target Discovery and Medicinal Chemistry

Year : 2023 | Volume : 01 | Issue : 01 | Page : 49 54
    By

    Neha Sahu,

  • Rizwan Arif,

  1. Research Scholar, Lingaya’s Vidyapeeth, Faridabad, Haryana, India
  2. Research Scholar, Lingaya’s Vidyapeeth, Faridabad, Haryana, India

Abstract

Above the past few decades, the prevalence of allergy illnesses has been steadily rising, impacting 20–30% of the world’s population. Multiple targets are involved in allergic reactions to infections of the skin, digestive tract, and respiratory system. Developing medications with a good curative efficacy and minimal side effects while utilizing novel multi-targets and processes in accordance with the clinical features of various allergic populations and allergens is the primary challenge facing research on anti-allergy therapies. The knowledge on possible therapeutic targets and the medicinal chemistry of synthetic anti-allergy small molecules are the main topics of this review. With reference to leukotriene production, wascium channel blockers, inhibitors of Th2 cytokines, histamine-1/4 receptor antagonists, and leukotrienes, the structure-activity relationship and the mechanism of compound-target interaction were highlighted. The investigation of chemical scaffold optimization and modification for various lead compounds, which is compiled in this review, should serve as a valuable resource for the drug design of related and promising research, such as allergy, in addition to improving the success rate and effectiveness of virtual screening for antiallergic drugs.

Keywords: Allergic reactions, medications, medicinal chemistry, antiallergic drugs, anti-allergy therapies, synthetic anti-allergy small molecules

[This article belongs to International Journal of Advance in Molecular Engineering ]

How to cite this article:
Neha Sahu, Rizwan Arif. Revolutionizing Anti-Allergy Medications: A Comprehensive Review of Target Discovery and Medicinal Chemistry. International Journal of Advance in Molecular Engineering. 2024; 01(01):49-54.
How to cite this URL:
Neha Sahu, Rizwan Arif. Revolutionizing Anti-Allergy Medications: A Comprehensive Review of Target Discovery and Medicinal Chemistry. International Journal of Advance in Molecular Engineering. 2024; 01(01):49-54. Available from: https://journals.stmjournals.com/ijame/article=2024/view=192838


References

  1. Savouré, J. Bousquet, J. J. K. Jaakkola, M. S. Jaakkola, B. Jacquemin, R. Nadif, Worldwide prevalence of rhinitis in adults: A review of definitions and temporal evolution. Clin. Transl. Allergy 12, e12130 (2022).
  2. Bai X., Chai Y., Shi W., Li Y., Zhang T., Liu P. (2020). Lonicera japonica polysaccharides attenuate ovalbumin-induced allergic rhinitis by regulation of Th17 cells in BALB/c mice. Funct. Foods 65, 103758. 10.1016/j.jff.2019.103758
  3. Bui T. T., Fan Y., Piao C. H., Nguyen T. V., Shin D.-u., Jung S. Y., et al. (2020). Piper nigrum extract improves OVA-induced nasal epithelial barrier dysfunction via activating Nrf2/HO-1 signaling. Cell Immunol. 351, 104035. 10.1016/j.cellimm.2019.104035
  4. Cavalcanti R. F. P., Gadelha F. A. A. F., de Jesus T. G., Cavalcante-Silva L. H. A., Paiva Ferreira L. K. D., Paiva Ferreira L. A. M., et al. (2020). Warifteine and methylwarifteine inhibited the type 2 immune response on combined allergic rhinitis and asthma syndrome (CARAS) experimental model through NF-κB pathway. Immunopharmacol. 85, 106616. 10.1016/j.intimp.2020.106616.
  5. Jin C., Ye K., Luan H., Liu L., Zhang R., Yang S., et al. (2020). Tussilagone inhibits allergic responses in OVA-induced allergic rhinitis Guinea pigs and IgE-stimulated RBL-2H3 cells. Fitoterapia 144, 1–7. 10.1016/j.fitote.2020.104496
  6. Lou H., Wang X., Wei Q., Zhao C., Xing Z., Zhang Q., et al. (2020). Artemisia annua sublingual immunotherapy for seasonal allergic rhinitis: a multicenter, randomized trial. World Allergy Organ. J. 13, 100458. 10.1016/j.waojou.2020.100458
  7. Piao C. H., Fan Y. J., Nguyen T. V., Song C. H., Chai O. H. (2020). Mangiferin alleviates ovalbumin-induced allergic rhinitis via Nrf2/HO-1/NF-κB signaling pathways. J. Mol. Sci. 21, 1–12. 10.3390/ijms21103415
  8. Saito S., Takagi H., Wakasa Y., Ozawa K., Takaiwa F. (2020). Safety and efficacy of rice seed-based oral allergy vaccine for Japanese cedar pollinosis in Japanese monkeys. Immunol. 125, 63–69. 10.1016/j.molimm.2020.06.019
  9. Sheibani V., Mandegary A., Vazifekhahan E., Kasbzade Z., Asadi A., Sharififar F. (2019). Zataria multiflora extract improves spatial memory and learning capacity in scopolamine-induced amnesic rats. Avicenna J. Phytomedicine 9, 587–596. 10.22038/AJP.2019.13540
  10. Shin S. -H., Ye M. -K., Lee D. -W., Che M. -H. (2020). Immunomodulative effects of Chamaecyparis obtusa essential oil in mouse model of allergic rhinitis. Molecules 25, 4517. 10.3390/molecules25194517
  11. Zhang Y., Kang H. (2020). Protective effect of Asarum sieboldii essential oil on ovalbumin induced allergic rhinitis in rat. Rep. 40, 1–9. 10.1042/bsr20191370
  12. Zhang Y., Zhang L. (2019). Increasing prevalence of allergic rhinitis in China. Allergy Asthma Immunol. Res. 11, 156–169. 10.4168/aair.2019.11.2.156
  13. Lou H., Huang Y., Ouyang Y. Artemisia annua-sublingual immunotherapy for seasonal allergic rhinitis: a randomized controlled trial. 2020;75:2026–2036. doi: 10.1111/all.14218.
  14. Li Y, An Y, Hao Y, Zhang L, Ouyang Y. Prevalence of sensitization to specific allergens in allergic patients in Beijing, China: a 7-year retrospective stud Asian Pac J. Allergy Immunol 2021. Epub ahead of print.
  15. Lou H, Wang X, Wei Q, Zhao C, Xing Z, Zhang Q, et al. Artemisia annua sublingual immunotherapy for seasonal allergic rhinitis: a multicenter, randomized trial. World Allergy Organ J. 2020 Sep 8;13(9):100458.
  16. Lou H, Huang Y, Ouyang Y, Zhang Y, Xi L, Chu X, et al. Artemisia annua-sublingual immunotherapy for seasonal allergic rhinitis: a randomized controlled trial. Allergy 2020 Aug;75(8):2026–36.
  17. Ansotegui IJ, Melioli G, Canonica GW, Caraballo L, Villa E, Ebisawa M, et al. IgE allergy diagnostics and other relevant tests in allergy, a World Allergy Organization position paper. World Allergy Organ J. 020 Feb 25;13(2):100080.
  18. Subspecialty Group of Rhinology, Editorial Board of Chinese Journal of Otorhinolaryngology Head and Neck Surgery, Subspecialty Group of Rhinology, Society of Otorhinolaryngology Head and Neck Surgery, Chinese Medical Association. Chinese guidelines for diagnosis and treatment of allergic rhinitis (2022, revision). Chin J Otorhinolaryngol Head Neck Surg, 2022,57(02):106–129
  19. Deng ZY, Liu XJ, Sa RN et al (2021) Epidemiological investigation of allergic rhinitis in central cities and countrysides of Inner Mongolia region. Chin J Otorhinolaryngol Head Neck Surg 56(06):635–642
  20. Yang J, Shen Z, Liu L et al (2022) Clinical efficacy and safety of Artesimia annua-sublingual immunotherapy in seasonal allergic rhinitis patients based on different intervention time. Int Arch Allergy Immunol 183(8):852–859
Regular Issue Subscription Review Article
Volume 01
Issue 01
Received 15/12/2023
Accepted 29/12/2023
Published 19/01/2024
268

Login


My IP

PlumX Metrics